Literature DB >> 34164699

Advance Care Directives Among a Population-Based Sample of Young Adults with Congenital Heart Defects, CH STRONG, 2016-2019.

Sherry L Farr1, Karrie F Downing2, Anthony Goudie3, Scott E Klewer4, Jennifer G Andrews4, Matthew E Oster2,5.   

Abstract

Little is known about advance care planning among young adults with congenital heart defects (CHD). Congenital Heart Survey to Recognize Outcomes, Needs, and well-beinG (CH STRONG) participants were born with CHD between 1980 and 1997, identified using active, population-based birth defects surveillance systems in Arkansas, Arizona and Atlanta, and Georgia, and surveyed during 2016-2019. We estimated the percent having an advance care directive standardized to the site, year of birth, sex, maternal race, and CHD severity of the 9312 CH STRONG-eligible individuals. We calculated adjusted odds ratios (aOR) and 95% confidence intervals (CI) for characteristics associated with having advance care directives. Of 1541 respondents, 34.1% had severe CHD, 54.1% were female, and 69.6% were non-Hispanic white. After standardization, 7.3% had an advance care directive (range: 2.5% among non-Hispanic blacks to 17.4% among individuals with "poor" perceived health). Individuals with severe CHD (10.5%, aOR = 1.6, 95% CI: 1.1-2.3), with public insurance (13.1%, aOR = 1.7, 95% CI: 1.1-2.7), with non-cardiac congenital anomalies (11.1%, aOR = 1.9, 95% CI: 1.3-2.7), and who were hospitalized in the past year (13.3%, aOR = 1.8, 95% CI: 1.1-2.8) were more likely than their counterparts to have advance care directives. Individuals aged 19-24 years (6.6%, aOR = 0.4, 95% CI: 0.3-0.7) and 25-30 years (7.6%, aOR = 0.5, 95% CI: 0.3-0.8), compared to 31-38 years (14.3%), and non-Hispanic blacks (2.5%), compared to non-Hispanic whites (9.5%, aOR = 0.2, 95% CI: 0.1-0.6), were less likely to have advance care directives. Few young adults with CHD had advance care directives. Disparities in advance care planning may exist.

Entities:  

Keywords:  Advance care directive; Congenital heart defect; Congenital heart disease; Living will

Year:  2021        PMID: 34164699     DOI: 10.1007/s00246-021-02663-5

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  2 in total

1.  2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Karen K Stout; Curt J Daniels; Jamil A Aboulhosn; Biykem Bozkurt; Craig S Broberg; Jack M Colman; Stephen R Crumb; Joseph A Dearani; Stephanie Fuller; Michelle Gurvitz; Paul Khairy; Michael J Landzberg; Arwa Saidi; Anne Marie Valente; George F Van Hare
Journal:  Circulation       Date:  2019-04-02       Impact factor: 29.690

2.  Age- and Lesion-Related Comorbidity Burden Among US Adults With Congenital Heart Disease: A Population-Based Study.

Authors:  Anushree Agarwal; Robert Thombley; Craig S Broberg; Ian S Harris; Elyse Foster; Vaikom S Mahadevan; Anitha John; Eric Vittinghoff; Greg M Marcus; R Adams Dudley
Journal:  J Am Heart Assoc       Date:  2019-10-02       Impact factor: 5.501

  2 in total
  1 in total

1.  Prevention and awareness of birth defects across the lifespan using examples from congenital heart defects and spina bifida.

Authors:  Sherry L Farr; Catharine Riley; Alissa R Van Zutphen; Timothy J Brei; Vinita Oberoi Leedom; Russell S Kirby; Laura J Pabst
Journal:  Birth Defects Res       Date:  2021-12-18       Impact factor: 2.661

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.